Specifically, there were similar incidences of hypoglycemia, urinary tract infections (UTI), genital infections, hypovolemia, and fractures observed between individuals treated with SGLT2 inhibitors and those administered a placebo ( 7 Conclusion This literature review has illuminated the potential roles of DPP-IV and SGLT2 inhibitors in the management of PTC, albeit with limited exploration thus far
Since 2020, 8 of the 20 published clinical trials have focused on neurodevelopmental and neuropsychiatric/cognitive disorders, exhibiting a significant rise in clinical trials exploring sulforaphanes efficacy in the CNS compared to the previous two decades where only two of 57 trials focused on ASD alone with no published trials examining other CNS disorders (Supplementary Table 1)
Liraglutide (Saxenda) Liraglutide is a medication used to manage type 2 diabetes and obesity
Do Ozempic and retatrutide have the same side effects
10.1038/s42003-023-05624-1 168 SprowlJ
Nutritional Challenges of Incretin-Based Obesity Management Medications: Implications for Clinical Practice